Zombie ETFs Spread as Small Funds Struggle

Less than $50 million after three years. That's the threshold defining a zombie exchange-traded fund, and Bloomberg Intelligence says the population of those products is growing as issuers keep launching niche vehicles that fail to gather assets.

The immediate consequence is simple: more closures, more forced exits, and a harsher test for smaller ETF sponsors. Athanasios Psarofagis of Bloomberg Intelligence made that point on Bloomberg's "ETF IQ," where he joined Katie Greifeld, Scarlet Fu and Eric Balchunas to discuss the rise in funds that are old enough to have proved themselves and still too small to matter.

Background

The definition here is narrow and useful. A zombie ETF is a fund that is at least three years old and manages less than $50 million, according to Bloomberg Intelligence. That strips away the marketing gloss. An ETF gets time to build a track record, attract advisers, and find distribution. If it still can't cross $50 million, the market has already delivered its verdict.

That matters because the ETF business rewards scale with almost brutal efficiency. Big funds cut fees, dominate trading volume, and pull in more assets because they're already liquid. Small funds don't get that luxury. They sit on platforms, consume operating budget, and struggle to justify their existence unless they serve a very specific pocket of demand. Investors know that. Issuers know it too.

The discussion lands in an industry that keeps multiplying products anyway. New launches chase themes, factors, options income, crypto-linked demand and ever narrower slices of the market. Some of that innovation sticks. A lot of it doesn't. The result: a shelf full of listed products that trade lightly, attract little institutional interest, and live under a constant cloud of liquidation risk. That's the other side of the same boom covered in the race to build investable AI narratives and, in commodities, the scramble for tactical exposure when headlines move prices.

What this means

The ETF market is not saturated. It is crowded. There's a difference. Crowded markets still produce winners, but they punish weak products fast and without sentiment. A growing zombie population tells you launch discipline has slipped. Too many issuers are putting products on exchange first and hoping distribution arrives later. That's backwards. In this business, distribution is the business.

Investors should read the zombie count as a closure pipeline. Funds with low assets and thin trading don't just look vulnerable; they are vulnerable. If they shut, holders can be pushed into taxable events, lose a tool they wanted for portfolio construction, or face wider spreads before the end. The largest firms gain from that churn because every liquidation sends assets hunting for a new home, and the easiest home is usually the cheapest, deepest fund already sitting at scale.

But the pressure won't fall evenly. Giant issuers can keep marginal products alive longer because a weak fund barely dents a huge platform. Smaller shops don't have that cushion. One failed launch can tie up capital, staff time and exchange costs for years. That changed when rates rose and financing stopped being free. In a pricier capital environment, dead weight gets cut faster. The same discipline now showing up across corporate balance sheets — and in travel names under fuel strain, as seen in WestJet's financing standoff — is hitting asset management too.

There's another consequence. The spread of zombie ETFs weakens the industry's favorite sales pitch that every investor need can be met by a listed wrapper. That's true in theory. It fails in practice when products lack assets, liquidity and staying power. An ETF isn't useful just because it exists. It has to trade well, hold enough assets to survive, and give investors confidence it won't disappear after one bad year.

If an ETF is three years old and still below $50 million, the market has already delivered its verdict.

The warning is not that ETFs are in trouble. The structure remains one of the most efficient vehicles in modern markets, with broad adoption across institutions and retail investors. For basic context on the vehicle itself, see exchange-traded funds. The warning is that product supply has outrun durable demand in one slice of the market. That's a business problem before it becomes an investor problem.

The broader market backdrop helps explain why this issue is surfacing more clearly now. Flows keep concentrating in a handful of giant products. Fee pressure hasn't eased. And advisers are less willing to experiment with tiny funds when plain-vanilla exposures are cheap and highly liquid. For reference on how listed funds fit into regulated fund markets, the U.S. investor education framework and the SEC's investment management division lay out the basics. The market's message is harsher: novelty doesn't deserve assets. Results do.

That leaves issuers with a blunt choice. Build fewer funds with clearer use cases, stronger seed capital and actual distribution support. Or keep feeding the zombie pile and accept that closures will define the next phase of ETF competition. There isn't a middle path anymore.

What to watch next is fund-by-fund triage. Issuers will decide over the coming quarters whether to merge, cut fees, or liquidate subscale products as they review midyear asset levels, and any fresh closure notices filed with the SEC will show which zombie ETFs ran out of time first.